|
<section><section data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.jpg" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section><span>关注</span></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><section><section><section><section><section><section><section><section><section><section><br /></section><section><span>受到新冠疫情的影响,全球经济严重受挫,即便是全球排名领先的巨头也难以免俗,美敦力公司的整体业务也因新冠疫情普遍下滑,据2020年5月21日美敦力发布的2020财年Q4和2020全年财报(2019年3月-2020年3月)显示,美敦力<span>Q4营收为<strong>60亿美元</strong>,同比下滑<strong>26%</strong></span>,2020财年的整体营收下降<strong>5.4%</strong>。其中,恢复治疗业务(RTG)(脑疗法,脊柱,特殊疗法和疼痛疗法部门)Q4营收为<strong>14.90亿美元</strong>,同比下降了<strong>33%</strong>;2019财年该业务中营收<strong>77.25亿美元</strong>,同比下降<strong>5.6%</strong>。在恢复治疗业务中,脑治疗、脊柱、特殊疗法和疼痛治疗均出现大幅下跌,下跌幅度在<strong>26%-43%之间</strong>。</span></section><section><section><br /></section><section><span><p><img src="image/20201014/4a8de3e563ce2abb057aa17af61c7419_2.jpg" /></p></span></section><p><br /></p><section data-support="96编辑器" data-style-id="22631"><section><section><p><strong>01</strong></p></section><section><p><strong>继续加码手术机器人领域</strong></p></section></section></section><section><br /></section><section><span>面对脊柱手术领域因疫情带来的巨大营收下滑,美敦力的策略是继续加码手术机器人领域,7月15日,美敦力宣布将以每股约7欧元的价格收购定制脊柱植入物制造商Medicrea来提高脊柱业务。据悉,目前双方已经签署协议,截止到目前,收购金额未披露。</span></section><p mpa-paragraph-type="body"><br /></p><p mpa-paragraph-type="body"><span>总部位于法国里昂的Medicrea,是全球领先的提供治疗复杂脊柱疾病的个性化分析服务和种植体解决方案的开发和制造商。旗下的产品<strong>Medicrea UNiD自适应脊柱智能(ASI)</strong>,是美敦力决定收购该公司的关键,该产品<strong>支持外科医生在术前规划中的工作流程并创建用于手术的个性化植入物解决方案</strong>。</span></p><p mpa-paragraph-type="body"><span><br /></span></p><p><span>Medicrea针对患者自身情况,结合人工智能和预测模型,构建了 UNiD自适应脊柱智能(ASI)。该平台基于人工智能和患者临床数据开发产品,包括自适应智能脊柱植入材料、患者特异性3D打印椎间融合和脊柱内固定系统。</span></p><p><span><br /></span></p><p><video width="100%" height="580" controls="controls"><source src="http://mpvideo.qpic.cn/0bf27uapyaaatmalj2qqwnpvb7od7t6qb7aa.f10002.mp4?dis_k=a015b1e6e89a81715a4504c5821ddf1e&dis_t=1602646919" type="video/mp4"></source></video></p><p><br /></p><section data-support="96编辑器" data-style-id="22631"><section><section><p><strong>02</strong></p></section><section><p><strong>美敦力已在该领域布局多年</strong></p></section></section></section><p><br /></p><p mpa-paragraph-type="body"><span>近年来,无论是国际骨科巨头或国内同领域新贵都在加大在骨科手术机器人领域的布局力度,可见这一极具潜力的市场被广泛认可,美敦力在该领域布局多年。早在1969年,美敦力就与Case Western Reserve大学合作研究,推出了可植入式背部脊椎刺激仪及脑刺激仪。</span></p><p mpa-paragraph-type="body"><br /></p><p mpa-paragraph-type="body"><span>1999年美敦力从最初的专注于心脏起搏治疗的企业,发展为多元化的全球性企业。通过收购市场领先的公司,将业务扩展到脊椎及整形手术、周边血管、体外除颤以及耳鼻喉科等各个领域。再这个领域内,美敦力不拘泥于单个产品的开发,而是从技术发展大趋势入手,将新兴技术与现有产品和技术平台进行结合,从更高的角度进行产品开发,进一步提升现有产品的竞争力,使得微创业务成为美敦力营收的中坚力量。</span></p><p mpa-paragraph-type="body"><br /></p><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/e817558f2fd4ab8c49c881ac6ae2c3ba_3.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><strong><span>主要并购</span></strong><strong></strong></p></section></section></section><section powered-by="gulangu"><section powered-by="gulangu"><section powered-by="gulangu"><section><p><strong><span>2002年 </span></strong><span></span></p><p><span>以2.69亿美元收购颈椎间盘公司SpinalDynamics;<br /></span></p><p><span><br /></span></p><p><br /></p><p><strong><span>2007年 </span></strong><span></span></p><p><strong><span><br /></span></strong></p><p><span>以39亿美元收购脊柱外科手术产品公司Kyphon;</span></p><p><span>以2.21亿美元与中国威高公司成立合资公司,开拓中国骨科市场(于2012年解散);</span></p><p><span><br /></span></p><p><br /></p><p><strong><span>2010年 </span></strong></p><p><span>以1.23亿美元收购骨骼肌肉再生技术公司Osteotech;</span></p><p><span><br /></span></p><p><br /></p><p><strong><span>2012年 </span></strong><span></span></p><p><span>以8.16亿美元收购康辉控股(中国)拓展在新兴市场的骨科和脊柱医疗服务;</span></p><p><span><br /></span></p><p><br /></p><p><strong><span>2015年 </span></strong><span></span></p><p><span>以499亿美元收购柯惠医疗,一举成为全球第一医疗公司;</span></p><p><span><br /></span></p><p><br /></p><p mpa-paragraph-type="body"><strong><span>2018年</span></strong></p><p mpa-paragraph-type="body"><span>以17亿美金收购了以色列手术机器人公司Mazor Robotics,推出机器人辅助脊柱手术平台;</span></p><p mpa-paragraph-type="body"><span><br /></span></p><p mpa-paragraph-type="body"><br /></p><p mpa-paragraph-type="body"><strong><span>2019年</span></strong></p><p mpa-paragraph-type="body"><span>收购主要生产钛合金椎间融合器的Titan Spine公司;</span></p><p mpa-paragraph-type="body"><span><br /></span></p><p mpa-paragraph-type="body"><strong><span>2020年</span></strong><span></span></p><p mpa-paragraph-type="body"><span>美敦力宣布收购AI手术数据分析公司Digital Surgery。</span></p></section></section></section></section></section><p mpa-paragraph-type="body"><br /></p><p mpa-paragraph-type="body"><br /></p><section data-support="96编辑器" data-style-id="22631"><section><section><p><strong>03</strong></p></section><section><p><strong>手术机器人大有可为</strong></p></section></section></section><p mpa-paragraph-type="body"><br /></p><p mpa-paragraph-type="body"><span>从美敦力在骨科领域的并购史可以看出,美敦力在此领域的业务结构正在向骨科手术机器人靠拢,同时,其他骨科巨头近年的并购操作也在向该领域加码,抢占市场。<br /></span></p><p mpa-paragraph-type="body"><br /></p><section data-tools="gulangu" data-id="2185"><section><section><section><section><strong><span>2018年11月</span></strong><span>,史赛克以14亿美元收购了K2M,来巩固其在脊柱治疗市场的地位。据预测,2019年该公司用于机器人植入膝关节和髋关节手术的MaKo系统增长达两位数。</span></section></section></section></section></section><p><br /></p><section data-tools="gulangu" data-id="2185"><section><section><section><section><strong><span>2018年9月</span></strong><span>,强生宣布收购德国3D打印脊柱植入物制造商Emerging Implant Technologies,意在扩大骨科应用。</span></section></section></section></section></section><p><br /></p><section data-tools="gulangu" data-id="2185"><section><section><section><section><strong><span>2019年2月份</span></strong><span>,施乐辉就收购与医疗器械制造商NuVasive进行谈判,交易总额超过30亿美元(约合人民币202亿元)。</span></section><section><br /></section></section></section></section></section><p mpa-paragraph-type="body"><strong><span>结语:</span></strong><span>骨科手术机器人有推进常规手术微创化、实现复杂手术标准化、促进高难度手术智能化促进高难度手术智能化、实现骨科医生学习曲线短程化等作用,不仅能够降低医疗风险,还让基层医院具备实施高难度手术的能力。未来,借助规划和操作相分离的“遥规划”技术,通过远程协作,骨科手术机器人的临床使用有助于解决医疗资源分布不均导致的“看病难、看病贵、救治不及时”的情况,同时助力我国骨科治疗水平的整体提升,这对于推动分级诊疗,有助于实现医疗资源均衡平等。</span></p><section><section data-autoskip="1"><p><br /></p></section></section></section></section></section></section></section></section></section></section></section></section><section><section data-color="#757576"><section><section><section><section data-brushtype="text"><strong>相关阅读</strong></section></section></section><section><section><br /></section></section><section data-width="100%"><section><section><section><section data-width="100%"><section data-color="#6aa9ad" data-custom="#59c3f9"><section><p><img src="image/20201014/2aac877ff9233ba5a66e7a5ff3a4febf_4.gif" /></p></section><section data-brushtype="text">戳一下,更有料!</section></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978429&idx=1&sn=3dc730e91b42ab792264edc8d20c661a&chksm=843f5e6ab348d77c81237056407e71362aabf790865ca8f86477c68d22af0cb49b2d6df0245f&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>IVD设备出口哪家强?2019年IVD检验设备出口简报!</span></a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978429&idx=2&sn=a15093420d6439ce3eb485c24264aff2&chksm=843f5e6ab348d77c8aff03e289bf1b1bf3f5eb6e99b8df9c0f89a4cf3a3c2f6953f125f51a96&scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2"><span>卒中患者秒变“钢铁侠”,全靠它!</span></a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978429&idx=5&sn=26f4821f2f9e2795590ad39cc6a8ee5e&chksm=843f5e6ab348d77c4c23f9cc0945a355012b01a33dd1a5f71f5d8e120a8fb0621011623f2870&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>河南最大“县医院”港交所上市了!</span></a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978260&idx=1&sn=9ad91543daac7b3e5bda13130f2c09da&chksm=843f5ec3b348d7d5bd053412e9f6bcfd27cee87fe1cda4cf873440124da17619b9c0834148c7&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2">骨科手术机器人市场风云再起,施乐辉重拳出击!</a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978260&idx=2&sn=3633b643f29f2499f1e98fcf2a813bdd&chksm=843f5ec3b348d7d584c7e96fc4eb7952f95dc552d9e19b6600ef350891f89f8902f97829b5a3&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2">迈瑞2020年半年报:显著实现高端客户群突破!</a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978161&idx=1&sn=c57a914ea63c34f73ae2b849b7c903da&chksm=843f5966b348d0707544738a7f10622eec1c69ec9a7f2188ada6905c3aeb9b8f7c853fcb4311&scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2">2020年上半年国内医疗器械融资盘点,华大智造独占IVD鳌头</a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652978161&idx=3&sn=7147428a4c99f89f066e93b4efbef0c9&chksm=843f5966b348d0705272969d0ed96028cf1234b018e089e5e3f8e0c1dc4de0e4594838436a9c&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2">心电医械出口哪家强?2019心电医械出口简报!</a><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><br /></section><section data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&mid=2652977976&idx=1&sn=d4f96aac54d4626d4fa4d42237c05874&chksm=843f59afb348d0b96c066d97907d0d062e7452fa83ca4074585d461c21a44ea0653847e07a94&scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2">生产商全景图:有关呼吸机的都在这里</a></section></section></section></section></section></section></section></section></section><p><br /></p><p><span>商务合作:4008228766@qixieke.com</span></p><p><br /></p><p><p><img src="image/20201014/aad9f56b0707b5374bbac6273a663447_5.jpg" /></p></p></section>
|
|